Inactive Instrument

All News SEMR PARA

Equities

LGST

KYG8028L1077

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

Semper Paratus Acquisition Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 29	CI
SEMR PARA : Tevogen Bio CEO Highlights Expected Reporting of a $94.9 Million Liability Elimination, AI Initiative, and Leadership Appointments - Form 8-K	Apr. 26	PU
Tevogen Bio Holdings Inc., a Cell Therapy Company, Announces Completion of Business Combination and is to be Listed on Nasdaq Under Ticker TVGN	Feb. 14	AQ
Semper Paratus Acquisition Corporation(NasdaqGM:LGST) dropped from NASDAQ Composite Index	Feb. 13	CI
Tevogen Bio Inc completed the acquisition of Semper Paratus Acquisition Corporation from a group of shareholders in a reverse merger transaction.	Feb. 13	CI
Semper Paratus Acquisition Shareholders Approve Tevogen Bio Deal	Feb. 01	MT
Semper Paratus Acquisition Corporation’s Shareholders Approve Business Combination with Tevogen Bio	Feb. 01	AQ
Semper Paratus Acquisition Corporation Announces Anticipated Listing of Tevogen Bio Holdings Inc. on Nasdaq	Jan. 24	AQ
Tevogen Bio Inc. and Semper Paratus Acquisition Corporation Announce Effectiveness of Registration Statement for Business Combination	Jan. 05	AQ
Semper Paratus Acquisition : Submission of Matters to a Vote of Security Holders - Form 8-K	Dec. 18	PU
Semper Paratus Acquisition Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 13	CI
Semper Paratus Acquisition Corporation Regains Compliance with Certain Nasdaq Listing Requirement	23-09-29	AQ
Semper Paratus Acquisition Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-21	CI
Semper Paratus Acquisition to Merge With Tevogen Bio; to Bring Tevogen Public	23-06-29	MT
Biotech firm Tevogen Bio enters $1.2 bln SPAC deal for US listing	23-06-29	RE
Biotech firm Tevogen Bio to go public in $1.2 billion SPAC deal	23-06-29	RE
Tevogen Bio to Become Publicly Listed on NYSE via Business Combination with Semper Paratus Acquisition Corporation	23-06-29	AQ
Tevogen Bio Inc entered into a merger agreement to acquire Semper Paratus Acquisition Corporation for $1.5 billion in a reverse merger transaction.	23-06-28	CI
Insider Sell: Semper Paratus Acquisition	23-06-08	MT
SEMPER PARATUS ACQUISITION CORP : Entry into a Material Definitive Agreement, Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	23-06-07	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News SEMR PARA

Equities

LGST

KYG8028L1077

All News

Filters